Takeda · 17 hours ago
Head of Contracts & Pricing
Boston, MA
Full-time
Hybrid
Director/Executive
$208K/yr - $327K/yr
12+ years expTakeda is a patient-focused company transforming patient care through the development of novel specialty pharmaceuticals. The Head of Contracts & Pricing will lead the strategic pricing strategy and commercial contracting management for the US Oncology business unit, overseeing advanced market access analytics and health economics functions.
BiotechnologyHealth CareManufacturingMedicalPharmaceutical
Responsibilities
Guides the evaluation of new pricing and contracting opportunities, and evaluation of identified leads to determining which possibilities meet the business unit objectives (financial and strategic) and establishment of the appropriate business steps to capitalize on these opportunities
Enhancing and managing processes across all access contracting decisions and implementing procedures to align cross-functional teams among access, government pricing, legal, marketing and compliance operations
Leading Pricing Governance Committee, Contract Assessments, Business Case Modeling and Analysis
Lead development and/or refresh business rules and playbooks that include appropriate reporting and compliance
Chair the Pricing Committee (comprised of senior leadership from sales, patient value & access, marketing, finance and legal) that is responsible for the pricing and contracting strategy across all US oncology customer segments. As the leader of this team, the Sr. Director frames strategic issues and defines the decision-making process for both high-level strategy and individual contract proposals. Committee recommendations are presented by this role to Senior Management for approval
Responsible for identifying information needs and conducting quantitative analysis of pricing and contracting matters. Responsible for all advanced market analytics and synthesis of information from all internal and external sources (market research, sales analytics, marketing research, and secondary data) and use this to develop complex models that compare alternative scenarios, strategies and terms
Manage and model GPO and VBA contract business cases and analytics
Oversee Gross to Net (GTN) forecast and models and partner with the forecasting and finance groups to ensure that price, discounts, rebate calculations and environmental risks, are conveyed, understood, and incorporated into financial projections for US OBU
Lead pricing analytics for in-line products and apply strategic thinking around pricing to ensure appropriate contracts for all commercial Oncology products meet the overall business goals. This is particularly important for late-stage products with the entry of generics and the need to balance Average Sales Price (ASP), price, share, and net revenue. Synthesize and develop solutions around this multivariate issue
The Sr Director will own and present recommendations to the US Oncology Leadership Team (US OLT)
Lead contract development with key payers – health maintenance organizations (HMOs) and pharmacy benefit managers (PBMs) -- Government -- Department of Veterans Affairs (VA), Federal Supply Schedule (FSS), Medicaid, Department of Defense (DOD) -- and Oncology GPOs. This activity requires influence and negotiation across functions as well as tracking and evaluation of contract performance
Responsible for helping to set Patient Value and Access office-based and field team goals and ensuring appropriate measures, metrics, and reports are in place to track progress. Partner with Insights & Analytics and IT to ensure measures are incorporated into all customer relationship management (CRM) and reporting tools and oversee the development of reports used to guide the business and activities
Train, coach, and develop staff in the complex discipline of pricing, contracting, and market analytics to ensure adequate commercial capabilities as the portfolio expands
Qualification
Required
Bachelor's Degree required, MBA preferred
12+ years of relevant experience required
Ability to analyze situations and data, synthesize and communicate results, and create recommendations and solutions to business problems required
Must have experience in the pharmaceutical marketplace and be an expert in the pricing, market, and market access nuances of both oral and injectable products and Oncology
The Sr. Director must be expert in Government price, Gross to Net calculations to act as internal expert and consultant to sales, marketing, and CFO
Experience and in-depth knowledge in obtaining reimbursement with third party commercial payers, Medicare Parts D and B, Medicaid, VA/DOD, integrated payer healthcare systems
Expert understanding and experience implementing provider focused reimbursement strategies, tactics, and support
Strong understanding of innovative pricing models. Proven expertise in pricing and pricing methodology
Leadership and influencing, strategic planning and organization, decision making, change management, and problem-solving skills
Excellent written and verbal communication to effectively convey strategic and technical market access information/issues to executives and access staff
Demonstrates strategic enterprise thinking to find innovative ways to serve patients, and build trust, our reputation and the business
Benefits
Short-term and/ or long-term incentives
Medical, dental, vision insurance
A 401(k) plan and company match
Short-term and long-term disability coverage
Basic life insurance
A tuition reimbursement program
Paid volunteer time off
Company holidays
Well-being benefits
Up to 80 hours of sick time
Up to 120 hours of paid vacation
Company
Takeda
Takeda is a biopharmaceutical company that researches and develops pharmaceutical drugs.
10001+ employees
H1B Sponsorship
Takeda has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (45)
2024 (39)
2023 (38)
2022 (34)
2021 (44)
2020 (18)
Funding
Current Stage
Public CompanyTotal Funding
$2.46B2025-06-27Post Ipo Debt· $2.4B
2016-09-01Grant· $19.8M
2016-05-08Grant· $38M
Leadership Team
Christophe Weber
President and CEO
Schuyler Fairfield
Senior Vice President, Global Head of Supply Chain
Recent News
2026-01-14
Pharmaceutical Technology
2026-01-11
Company data provided by crunchbase